Caleb Downs
Story Poster
68:03
The Loochador Podcast: Analyzing Texas A&M's roster as spring ball looms
2 days ago by Billy Liucci
The dust on one portal window has settled as Mike Elko's Fightin' Texas Aggies are already hard at work in preparation for spring football. In this edition of the Loochador Podcast, Billy Liucci and David Nuño analyze A&M's roster as the calendar has flipped to February.
Story Poster
41:06
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, January 31)
3 days ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning ahead of men's basketball's trip to South Carolina. Liucci provided his thoughts on the Maroon & White's upcoming schedule, Marcel Reed's potential jump next season and more.
Story Poster
55:57
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, December 23)
1 mo ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Monday morning as game week has arrived for Texas A&M. Liucci previewed the Aggies' matchup with the Trojans in Las Vegas, Mike Elko's recent additions in the transfer portal and much more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Tale of the Tape: No. 15 Texas A&M at Auburn
2 mo ago by TexAgs
The finish to the 2024 regular season figures to be a tense one, and it begins on Saturday night when No. 15 Texas A&M ventures into a hostile Jordan-Hare Stadium to face a 4-6 Auburn team that is fighting for bowl eligibility down the stretch.
Story Poster
After key departures, Alabama figures to be tested this upcoming season
1 yr ago by Olin Buchanan
The Crimson Tide have emerged as one of the most powerful programs in college football over the last 15 years under the helm of Nick Saban. Despite sustained success, Alabama's outlook for 2023 appears unclear with the loss of star players to the NFL Draft including Bryce Young.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.